Genfit (GNFT) Competitors

Genfit (NASDAQ:GNFT) and Pharvaris (NASDAQ:PHVS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Which has preferable valuation and earnings, GNFT or PHVS?

Genfit has higher revenue and earnings than Pharvaris.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genfit	$67.00M	3.21	-$31.27M	N/A	N/A
Pharvaris	N/A	N/A	-$109.18M	-$3.01	-5.68

Do analysts prefer GNFT or PHVS?

Genfit currently has a consensus target price of $13.00, indicating a potential upside of 202.33%. Pharvaris has a consensus target price of $36.20, indicating a potential upside of 111.70%. Given Genfit's higher possible upside, equities research analysts plainly believe Genfit is more favorable than Pharvaris.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genfit	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pharvaris	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is GNFT or PHVS more profitable?

Genfit's return on equity of 0.00% beat Pharvaris' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genfit	N/A	N/A	N/A
Pharvaris	N/A	-38.52%	-36.69%

Which has more volatility & risk, GNFT or PHVS?

Genfit has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Pharvaris has a beta of -2.86, suggesting that its share price is 386% less volatile than the S&P 500.

Do insiders and institutionals hold more shares of GNFT or PHVS?

2.2% of Genfit shares are held by institutional investors. 4.2% of Genfit shares are held by company insiders. Comparatively, 11.8% of Pharvaris shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community favor GNFT or PHVS?

Genfit received 29 more outperform votes than Pharvaris when rated by MarketBeat users. Likewise, 69.70% of users gave Genfit an outperform vote while only 67.80% of users gave Pharvaris an outperform vote.

Company	Underperform	Outperform
Genfit	Outperform Votes 69 69.70%	Underperform Votes 30 30.30%
Pharvaris	Outperform Votes 40 67.80%	Underperform Votes 19 32.20%

Does the media favor GNFT or PHVS?

In the previous week, Pharvaris had 15 more articles in the media than Genfit. MarketBeat recorded 18 mentions for Pharvaris and 3 mentions for Genfit. Genfit's average media sentiment score of 1.53 beat Pharvaris' score of 0.62 indicating that Genfit is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genfit	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Pharvaris	6 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Genfit beats Pharvaris on 10 of the 13 factors compared between the two stocks.